The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 30 May 2006
doi: 10.1242/jcs.02995
Research Article
Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin
Goedele N. Maertens,
Peter Cherepanov,
and
Alan Engelman*
* Author for correspondence (e-mail: alan engelman{at}dfci.harvard.edu)
Transcriptional co-activator p75 is implicated in human cancer, autoimmunity and replication of human immunodeficiency virus type 1 (HIV-1) as a dominant integrase-interacting protein. Although characterized as chromatin associated, the normal biological role(s) of p75 remains fairly unclear. To gain insight into p75 function, we have characterized its cellular binding partners and report that JPO2, a recently identified Myc-binding protein, associates with p75 in vitro and in vivo. The pseudo HEAT repeat analogous topology (PHAT) domain of p75, which mediates its interaction with integrase, also mediates the interaction with JPO2, and recombinant integrase protein competes with JPO2 protein for binding to p75 in vitro. JPO2 binds p75 through a 61-residue (amino acids 58-119) region that is distinct from its Myc-interacting domain. In cells, JPO2 and p75 co-localize throughout the cell cycle, and both proteins concentrate on condensed chromosomes during mitosis. Strikingly, the association of JPO2 with chromatin strictly depends upon p75, similar to that of ectopically expressed integrase. Also similar to its effect on integrase, p75 stabilizes intracellular steady-state levels of JPO2 protein. Our results suggest a role for p75 in the Myc regulatory network, and indicate that p75 is a general adaptor protein tethering divergent factors to chromatin through its versatile integrase-binding domain.
This article has been cited by other articles:
|
|
|
|
 
Y. Botbol, N. K. Raghavendra, S. Rahman, A. Engelman, and M. Lavigne
Chromatinized templates reveal the requirement for the LEDGF/p75 PWWP domain during HIV-1 integration in vitro
Nucleic Acids Res.,
March 27, 2008;
36(4):
1237 - 1246.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. L. Brady, P. G. Fuerst, R. A. Dick, C. Schmidt, and D. F. Voytas
Retrotransposon Target Site Selection by Imitation of a Cellular Protein
Mol. Cell. Biol.,
February 15, 2008;
28(4):
1230 - 1239.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-C. Shun, N. K. Raghavendra, N. Vandegraaff, J. E. Daigle, S. Hughes, P. Kellam, P. Cherepanov, and A. Engelman
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration
Genes & Dev.,
July 15, 2007;
21(14):
1767 - 1778.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Cherepanov
LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro
Nucleic Acids Res.,
January 12, 2007;
35(1):
113 - 124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. De Rijck, L. Vandekerckhove, R. Gijsbers, A. Hombrouck, J. Hendrix, J. Vercammen, Y. Engelborghs, F. Christ, and Z. Debyser
Overexpression of the Lens Epithelium-Derived Growth Factor/p75 Integrase Binding Domain Inhibits Human Immunodeficiency Virus Replication
J. Virol.,
December 1, 2006;
80(23):
11498 - 11509.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Birtle and C. P. Ponting
Meisetz and the birth of the KRAB motif
Bioinformatics,
December 1, 2006;
22(23):
2841 - 2845.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2006
